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1.0 Introduction:
PHARM was developed to address operational costs associated with Space Shuttle component
failures, repair, and/or replacement processes by identifying components trending toward failure.
Thus PHARM mitigates impacts to operational testing and mission performances by providing
realistic need dates and historical performance data for component repair/replacement decisions
and logistic provisioning. BRSS developed under an IR&D and NASA contract an OMS Vehicle
Health Management testbed using qualification hardware in flight configuration.  The testbed
performs a complete and total automated checkout of an OMS Helium pressurization system.  In
the course of the automated checkout, key component performance data is saved, correlated and
used to develop, prove, and demonstrate PHARM technologies.  Via data acquisition, PHARM
provides trending and forecasting capabilities for mission scheduling. Figure 1 illustrates the
inter-relationship between various activities and PHARM.
Figure 1 PHARM’s Information Cycle
Development of a PHARM approach to operational systems (i.e. Shuttle, X vehicles, and
commercial applications) requires some initial steps to verify and validate that a PHARM
approach is a viable option.  PHARM’s foundation is based on applying Statistical Process
Controls (SPC) to component performance data to determine present and future
component/system health.  Therefore the accuracy and reliability of the data is crucial to
accurately trend and predict component performance.  Another key aspect of PHARM is to have
an “apples to apples” data storage and retrieval capability.  This is accomplished by tying into a
configuration management system where components are tracked through repairs, replacement,
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relocation etc.  PHARM’s component performance forecasting is initially based on testing cycles.
These cycles will need to be integrated with a scheduling system to provide a realistic mission
based need date for integration into the logistics scheduling database for component
repair/replacement decisions and logistics provisioning.
2.0 Scope:
This report discusses the PHARM infrastructure, forecasting development, and related databases
that make PHARM a total information cycle.  Much of the PHARM discussions are centered on
the Vehicle Health Management (VHM) OMS He pressurization system testbed located at the
Kennedy Space Center’s Launch Equipment Test Facility (LETF).
3.0 PHARM Underlying Infrastructure:
Determining the feasibility of applying PHARM to an existing system or new system requires
some initial investigations.  These investigations require a detailed look into each specific
component’s failure modes, testing requirements, data acquisition processes, and possible
modifications.
3.1 Failure Modes Analysis:
The first and probably the most important tasks were to understand and determine the most
common failure modes associated with a system/subsystem.  This was accomplished for the
components in the OMS helium testbed by reviewing and analyzing the failure modes and shuttle
fleet history of each component.  To understand the critical failure modes (defined as loss of crew
and/or vehicle), a review of the Failure Modes Effects Analysis (FMEA) was performed.
Determining the most common failure required an analysis of the Problem Report And Corrective
Action (PRACA) data system which contains the failure history and corrective action taken for
each of the components.  The analysis identified for the OMS/RCS He pressurization systems the
most common operational failure modes were associated with internal system leaks.  The
majority of these leak failures were caused by dried propellant residue, acid etching,
contamination, and operational wear.  Leak failures associated with dried propellant residue, acid
etching, and operational wear appear to lend themselves well to trending, because they can
gradually get worse over time. Contamination leak failures are caused by a piece of contaminant
flowing through the system causing an instantaneous discrepant condition and therefore is not a
good candidate for trending.  However a leak rate value outside SPC limit but within
requirements might be an indication of a contamination failure and impending problems.  The
current methods of operational checkout have a high degree of variability and an inefficient
method of data recording, storage, and tracking making it extremely difficult to collect and
analyze the data for trending.
3.2 Testing Process Analysis:
PHARM relies strongly on applying SPC techniques to trend and forecast component
performance.  This section will show the importance that accurate and reliable data has on
trending of component performance.  One of the most basic rules for applying some selective
SPC tools (run charts, x-bar charts, trending) states that a process must be in control.  Any unique
causes of data variations not associated with the process itself needs to be eliminated.  This leads
us into a discussion on the importance of understanding the testing and data collection process for
specific trendable failures and to obtain the most accurate and reliable data possible.
The failure analysis identified leaks to be the most common failure for the components in the
OMS/RCS helium pressurization system.  Addressing this failure mode would achieve the
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greatest ground processing savings.  The analysis on the testing processs found that the current
testing and data collection process had several unique causes of data variations (human biases,
additional leak sources, and temperature) that made trending unreliable.  These variations were
easily addressed using the VHM OMS helium testbed.  The testbed uses an expert system tool
providing real-time sequencing, analysis, state monitoring and close loop accounting.  This tool
was built with G2, an expert system shell developed by Gensym Corporation.
3.2.1 Elimination of Human biases:
Current testing and data collection processes on the shuttle OMS/RCS helium pressurization
systems are performed manually.  The VHM testbed and G2’s automated controls provided
automated testing procedures and data reading and recording, thus eliminating the human bias
factor in testing reading and recording data.  The use of G2 eliminates human intervention in
reading and recording data, providing a high degree of repeatability and accuracy in data
collection.
3.2.2 Reduction in Additional Leak Sources:
Current testing operations require numerous ground QD connections to the OMS/RCS helium
pressurization system checkout.  Each of these ground QD connections produces a potential leak
source, which may mask the actual component leak rate.  The testbed was used to develop
techniques that use onboard helium instead of ground supplied helium thus eliminating the
majority of the required ground QD connections, while also eliminating the additional leak source
concerns.
3.2.3 Temperature Variation Accountability:
Current leak check operations are performed with a standard leak stabilization time of 15 minutes
with the assumption that temperature is isothermal (constant) for the duration of the leak check.
This method of determining leak rates is fairly good, but the isothermal assumption does not
accurately represent conditions and at times provides misleading data.  For example, an
Environmental Control System (ECS) cycling on and off changes the external conditions of
system lines and components.  This has been proven to produce a sinusoidal effect on the systems
temperatures/pressure and thereby influencing the leak rates.  The G2 expert system at the testbed
uses real-time temperature and pressure data to calculate leak rates.  With the real-time leak rate
data, the standard leak stabilization time was automated by monitoring leak rates determining real
time leak stabilization.  This reduced the leak duration time from 15 minutes to approximately 5
minutes.  The reduction in stabilization time also reduces the potential effects of an ECS cycling.
3.3 Data Acquisition Process Analysis:
With the elimination of the previous defined variation there still remained a significant ‘data
toggle’ that tended to mask any chance of measuring accurately the components performance.  To
perform leak checks a running average over the last 60 seconds was used as pressure in the
calculation.  To eliminate this data toggle and the need to perform a running average the data
acquisition system was upgraded from a 12-bit to a 16-bit system.  The resultant measurements
from the pressure transducers were improved by an order of magnitude or better reducing the data
toggles from +/- 2 psi to +/- 0.02 psi.  Figure 2 and 3 illustrates the benefits and importance of
archiving the most accurate data possible.  Figure 2 is a run plot of measurements taken from a
common pressure transducer (p5) using the 12 and 16-bit data acquisition systems.  Also included
is the running average of the 12-bit system.  As can be seen the 16-bit system has significantly
reduced data toggles.  Using the 16-bit system eliminated the need to maintain a running average,
greatly simplifying G2’s automated procedures.
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Figure 3 shows the improvements the
16-bit system has on SPC using actual
tested leak rates.  The plot consists of
primary A regulator calculated leak
rates, which were recorded from both
the 12 and 16-bit data acquisition
system.  As expected the 16-bit data
acquisition system has a noticeable
improvement to the 12-bit system for
the leak rates.  The 16-bit system has a
71% reduction in the span between the
UCL and LCL as compared to the 12-
bit system.  The increased fidelity and
tighter control limits improves the
ability to determine the components
performance.  The most important
issue identified in this chart, and the
principal reason why it is so important to obtain the most accurate and reliable data possible, is
the difference in the trend lines.  The 12-bit trend line shows a downward trend while the 16-bit
system show and upward trend.  Although the data set is small, the 12-bit system has the potential
to lead to an erroneous conclusion.
3.4 Telemetry Data Acquisition Systems:
To augment PHARM applicability to different component failure modes and their particular
measurement data requirements, PHARM has developed two data collection systems.  One
accesses the Shuttle telemetry data stream or the Shuttle Data Center (SDC) for failure conditions
that need no measurement data enhancements.  The other is an embedded system, which will
demonstrate an alternative data collection system where accuracy and high speed data need to be
satisfied.  The development of the embedded system leveraged off an ongoing Boeing IR&D
16 Bit Data Acquisition
12 Bit Data Acquisition
12 Bit Averaged Data
Figure 2 12-bit vs 16-bit Data Acquisition System
Figure 3 Component Performance Plot 12-bit vs 16-bit Data Acquisition
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effort to develop an automated in-flight checkout system for the VHM OMS helium
pressurization system.  The embedded system acts as an autonomous remote health node
monitoring the system state.  When conditions satisfy ground testing requirements it runs
algorithms that calculate, collect, and store key measurement data to the hard drive for later
download and evaluation.  This eliminates the need for ground checkout operations.  The
improved accuracy in the measured data was achieved by using a 16-bit D/A board with a range
of 0 to 10 volts improving the match up between the in D/A board and instrumentation.  This year
(Calendar Year 2000) PHARM will develop the ability to acquire high speed trace data where
neural net applications can be applied to evaluate the health of a component.
To demonstrate PHARM applicability using certified Shuttle telemetry data from the SDC, a
multi mission web based data mining and analysis tool was developed called Spacecraft
Telemetry Analysis Tool (STAT).  The telemetry data is acquires based on Test Configuration
Identification Document (TCID), Greenwich Mean Time (GMT), and Instrumentation address or
Function Designator (FD).  STAT has the search functionality to acquire component performance
data in several ways.  One is to specify the exact time when the event occurred.  Another is to
identify a range in which the event was to occur where the engineer can zero in on events.  And
lastly uses an event based algorithm that looks for related component states and when they satisfy
some defined condition the needed data is then collected.  Once the performance data has been
collected, STAT uses Java based plotting features to display the data.  STAT applies SPC and
trending to aid in performance evaluations.
4.0 Data Analysis Trending and Predicting:
Once the underlying infrastructure has been investigated and the required data collection process
has been defined, the next step is to develop techniques to plot component health along with
trending and performance prediction.  As seen in Figure 3, plotting a component’s performance
applies common SPC tools X-Bar Charts with SPC limits and a trend or regression line.  The
difficult part is forecasting and providing a need date for repair/replacement and logistic
provisioning decisions.  Preliminary investigations indicate that forecasting performance is not as
trivial as first thought.  It appears that component failure mode and failure characteristics play an
important role in the development of prediction techniques.  It is hypothesized that there is basic
set of trendable failure characteristics for a wide range of components and/or component failure
modes where a common set of prediction techniques can be applied.  Some expected failure
characteristics are:
•  The data has a linear trend to a hard limit and the data maintains constant variation over
time.
•  The data has a linear trend to a hard limit but the data diverges over time.
•  The data is linear at first but the failure characteristic is exponential.
•  The data does not trend to a hard limit and diverges over time.
5.0 Database Integration:
For PHARM to be a complete informed maintenance cycle the ability to integrate with other
databases is needed.  Component tracking through its life cycle is essential for PHARM to
retrieve and store a particular component performance data.  PHARM developed a web based
application that integration with the Space Shuttle Program’s Configuration Verification
Accounting System (CVAS) database.  This system tracks the configuration of the orbiter’s
systems and components.  The application can query for a component’s mission history and
installation information using part and serial number or query for component’s part/serial number
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using mission history and component location.  This technology was used to develop SSAV, the
configuration management system for the Space Station Program.
Predicting component health for logistics provisioning and repair/replacement scheduling
required the ability to convert test cycle predictions to a usable mission based need data.  Access
to a mission manifest database will provide the needed mission scheduling information to support
logistics operations.
The established need date and historical performance data along with SPC and trending provided
by PHARM can be used to help mitigate impact to logistic operations in several key ways.  First,
PHARM can assist in logistics provisioning decisions, which are primarily based on component
failure rates.  PHARM can assist in this provisioning decision by providing evidence that the
component is not trending toward failure and thus provisioning decisions can be differed.  Or the
opposite may be true.  PHARM may provide evidence that the component is trending toward
failure earlier than expected and a provisioning decision needs to be expedited.  Logistics
repair/replacement decision and scheduling again is primarily based on component failure rates.
PHARM again can provide evidence that the scheduling decisions to repair/replaceme a
component can either be expedited or differed.
PHARMs integration into the mission manifest and logistics scheduling databases is slated for
this year (2000) and this will complete the information cycle.
6.0 In Summary:
PHARM was primarily developed to help mitigate operational costs associated with Shuttle
component failures, logistics provisioning and repair/replacement processing.  The full capability
of PHARM has yet to be seen, however some of the fallout technology is currently being
implemented and used in Shuttle, Space Station, and Spaceport Florida operations.  One of the
key advantages that rose out of PHARM’s development was STAT and its capabilities are an
excellent near real time engineering advisory tool, which is currently being used during Shuttle
launch and ground processing operations.
For PHARM to be applied effectively to any program, system, subsystem, and/or component the
following key factors need to be addressed.
1) Component failure analysis and feasibility study.
2) Obtain the most accurate measurement data possible
3) Acquire data from alternate data sources
4) Integrate with Configuration Management databases for an “apples to apples”
comparison of the data
5) Integrate with scheduling databases to mitigate provisioning, repair/relpacement
decisions
6) Make PHARM capability available so all potential users may benefit
PHARM is the integration of information across a project so every entity can make decisions
based on actual component performance.
